

| Biological Activity | |||||||||||||||||||||||||
| Synonyms | Flagecidin, NSC 76712 | ||||||||||||||||||||||||
| Chemical Name | (2R,3S,4S)-2-(4-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate | ||||||||||||||||||||||||
| Application | Anisomycin is activator of JNK (c-Jun N-terminal kinases) and p38 | ||||||||||||||||||||||||
| CAS Number | 22862-76-6 | ||||||||||||||||||||||||
| Purity | ≥99.0% | ||||||||||||||||||||||||
| Molecular Weight | 265.31 | ||||||||||||||||||||||||
| Molecular Formula | C₁₄H₁₉NO₄ | ||||||||||||||||||||||||
| SMILES | CC(=O)O[C@@H]1[C@H](CN[C@@H]1CC2=CC=C(C=C2)OC)O | ||||||||||||||||||||||||
| Target & IC50 | JNK, DNA synthesis | ||||||||||||||||||||||||
| Shipping | Gel Pack | ||||||||||||||||||||||||
| Storage | Store at -20°C | ||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| Solubility | |
| DMSO: 26.5 mg/mL (100 mM) Ethanol: 13.3 mg/mL (50 mM) |
| Product Description | |
Anisomycin is a phenylpyrolidine derivative shown to strongly activate the stress-induced MAP kinases JNK and p38. This activity results in the induction of the immediate-early genes: c-Fos, c-Jun, Fos B, Jun B and Jun D, and enhanced phosphorylation of p54/nrb, ATF-2, ERK, Caldesmon, IRS-1 and IRS-2. This compound behaves as a true signaling agonist, and has been implicated to play an important role in hyperosmolarity and UV-stimulated responses. Anisomycin has also been shown to increase the phosphorylation of p70 S6 kinase α. |